ARCHIVES

Yarbro-Chabner Debate Continues

This article is from The Cancer Letter archive.

Vol. 09 No. 17 | April 29, 1983

Download PDF Visit The Full Archive

Related Articles

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

Lippman Named UCSD Cancer Center Director

May 4, 2012

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004